Supplement: TX HB1586 | 2021-2022 | 87th Legislature | Fiscal Note (House Committee Report)
For additional supplements on Texas HB1586 please see the Bill Drafting List
Bill Title: Relating to health benefit plan coverage of clinician-administered drugs.
Status: 2021-05-17 - Referred to Business & Commerce [HB1586 Detail]
Download: Texas-2021-HB1586-Fiscal_Note_House_Committee_Report_.html
Bill Title: Relating to health benefit plan coverage of clinician-administered drugs.
Status: 2021-05-17 - Referred to Business & Commerce [HB1586 Detail]
Download: Texas-2021-HB1586-Fiscal_Note_House_Committee_Report_.html
| TO: |
Honorable Tom Oliverson, Chair, House Committee on Insurance |
| FROM: |
Jerry McGinty, Director, Legislative Budget Board
|
| IN RE: |
HB1586 by Lucio III (relating to health benefit plan coverage of clinician-administered drugs.), Committee Report 1st House, Substituted |
No significant fiscal implication to the State is anticipated.
The bill would amend the Insurance Code relating to health benefit plan coverage of clinician-administered drugs. It is assumed that the duties and responsibilities associated with implementing the provisions of the bill could be accomplished by utilizing existing resources.
Local Government Impact
No fiscal implication to units of local government is anticipated.
| Source Agencies: | 327 Employees Retirement System, 454 Department of Insurance, 529 Hlth & Human Svcs Comm, 710 Texas A&M Univ System Admin, 720 UT Sys Admin |
| LBB Staff: | JMc, AAL, MB, MPUK |
